Major metabolic pathway for N-methyl-2-pyrrolidone in humans

Bengt Åkesson, Bo A Jönsson

Research output: Contribution to journalArticlepeer-review

64 Citations (SciVal)


The aim was to study the metabolic pathway for N-methyl-2-pyrrolidone (NMP) in humans. Three healthy male volunteers were administered 100 mg NMP orally. All urine was collected during nine consecutive days. The identification and quantification of the metabolites were performed by gas chromatography/mass spectrometry (GC/MS). NMP, 5-hydroxy-N-methyl-2-pyrrolidone (5-HNMP), N-methylsuccinimide (MSI), and 2-hydroxy-N-methylsuccinimide (2-HMSI) were found in urine. The mean excreted fractions for NMP, 5-HNMP, MSI, and 2-HMSI were 0.8%, 44%, 0.4%, and 20%, respectively. There was no conjugation with glucoronic acid or sulfate or either 5-HNMP or 2-HMSI. One-third of the orally dosed NMP was not recovered in urine as either NMP, 5-HNMP, MSI, or 2-HMSI. The half-lives for 5-HNMP, MSI, and 2-HMSI in urine were approximately 4, 8, and 17 hr, respectively.
Original languageEnglish
Pages (from-to)267-269
JournalDrug Metabolism and Disposition
Issue number2
Publication statusPublished - 1997

Subject classification (UKÄ)

  • Environmental Health and Occupational Health


Dive into the research topics of 'Major metabolic pathway for N-methyl-2-pyrrolidone in humans'. Together they form a unique fingerprint.

Cite this